Stay updated on Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding cabozantinib for advanced renal cell carcinoma and the addition of a new version identifier.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.SummaryDifference1%
Stay in the know with updates to Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.